These therapies work by mimicking gut hormones to regulate blood sugar, suppress appetite and prolong satiety, making them highly effective in managing type 2 diabetes and obesity, conditions widely prevalent in India now
GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
Before medication begins, a Twin provider reviews the members labs, weight, current medications, and health history
Polydeoxyribonucleotide exerts opposing effects on ERK activity in human skin keratinocytes and fibroblasts
N1110, Promega)
Catch #1: The coverage has an expiration date It helps to know where GLP-1s come from
